Search for: "Lupin Pharmaceuticals"
Results 61 - 80
of 175
Sort by Relevance
|
Sort by Date
18 Jul 2011, 8:21 am
Lupin, Sanofi v. [read post]
13 Jul 2011, 3:04 am
(The SPC Blog) Doha+10: On November 14, 2011, a meeting at WIPO in Geneva to discuss the Doha Declaration (KEI) Docs at BIO: Session on IP challenges for personalised medicine (Patent Docs) France to reform its pharmaceutical regulatory system… with possible global implications! [read post]
6 Jul 2011, 2:21 am
One District Court has an answer: Nycomed v Tolmar (FDA Law Blog) Trizivir (Abacavir) – US: ViiV Healthcare files patent infringement complaint against Lupin in response to Para IV certification filing (Patent Docs) Welchol (Colesevelam) – US: Glenmarks settles litigation with Daiichi Sankyo, Genzyme (GenericsWeb) Xeloda (Capecitabine) – US: Hoffman-La Roche files patent infringement suits against Accord Healthcare, Teva and Roxane following Para IV certification filing… [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
23 Jun 2011, 11:16 pm
Reddys Laboratories Mylan Pharmaceuticals Teva Aurobindo Pharma Glenmark Generics Lupin Wockhardt These companies and others are now allowed to sell their versions of Levaquin in the United States, which so far has earned $ 1.45 billion for a period of 12 months ending in September, 2010. [read post]
15 Jun 2011, 4:56 am
Lupin Ltd. et al. [read post]
1 Jun 2011, 5:51 pm
Karst – Last week, in a seven-page response, FDA denied an October 18, 2010 Citizen Petition submitted on behalf of Lupin Limited (“Lupin”) requesting that FDA determine that Teva Pharmaceuticals USA, Inc. [read post]
31 May 2011, 8:38 pm
General WIPO SCP16: Joint proposal of the African Group and the Development Agenda Group on a work program on Patents and Health (Knowledge Ecology International) Rogue pharmacies slide under Google radar (IP Osgoode) Australia slips further out-of-step on pharmaceutical extensions (Patentology) EU: Proposed EU Customs Regulation may not dispel fear of wrongful drug seizures (IP Watch) EU: Karl De Gucht writes Andris Piebalgs on topic of European Union IPR demands on India and other… [read post]
25 May 2011, 4:59 am
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
10 May 2011, 11:59 pm
Wyeth has also reached agreements with other companies as well, including Sun Pharma, Lupin, Aurobindo Pharma, Ranbaxy and Teva. [read post]
1 May 2011, 2:02 pm
Lupin, concerning patent term extensions. [read post]
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A historical perspective on the gene patent controversy… [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent lawsuit… [read post]
3 Apr 2011, 9:44 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
29 Mar 2011, 9:19 pm
General Pharmaceutical, biotechnology and chemical inventions – world protection and exploitation (FDA Law Blog) Gene patents on the high seas: who owns the ocean’s IP? [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
7 Feb 2011, 6:53 pm
In Ortho-McNeil Pharmaceutical, Inc. v. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
20 Jan 2011, 1:03 pm
., Lupin Limited, and Lupin Pharmaceuticals, Inc. [read post]
